Magnetic polymer nanocapsules suitable for therapy, in particular anti-cancer therapy

By developing magnetic polymer nanocapsules based on liquid oil cores, the problems of low encapsulation efficiency and poor targeting of hydrophobic active substances in the prior art are solved, and efficient, selective targeting and controlled release to cancer cells is achieved, reducing the side effects of anti-cancer therapy.

CN120475993APending Publication Date: 2025-08-12POLAND JIADE AG
1 Cites 0 Cited by

Patent Information

Application Number
CN202380072570.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-08-11
Filing Date
2023-08-11
Publication Date
2025-08-12

AI Technical Summary

Technical Problem

The polymer nanocapsules with high stability and magnetic properties in the prior art are used in anti-cancer therapy, resulting in low encapsulation efficiency, insufficient release concentration, poor targeting, and side effects, and the existing system size is large and difficult to penetrate cancer cells.

Method used

Magnetic polymer nanocapsules based on liquid oil cores are developed, containing magnetic iron oxide nanoparticles and hydrophobic active substances. Through static magnetic field navigation and alternating magnetic field release, efficient targeted delivery is achieved. The capsule size is small and has good biocompatible.

Benefits of technology

It achieves efficient encapsulation and release of hydrophobic active substances to cancer cells, avoids toxicity to normal cells, provides selective targeting and controlled release, and reduces the side effects of anti-cancer therapy.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

Disclosed are magnetic polymer nanocapsules, which are core-shell polymer nanocapsules carrying hydrophobic active substances, comprising magnetic iron oxide nanoparticles, and their use in anti-cancer therapy.
Need to check novelty before this filing date? Find Prior Art